Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Kwin Grauer Insider Profile
4 Followers
Daniel Kwin Grauer, Director at Defence Therapeutics, holds 106.67K shares in Uniserve Communications (Ticker: TSE:USS), holds 18.50K shares in Defence Therapeutics (Ticker: DTCFF). Most recently, Daniel Kwin Grauer Bought ― shares of Uniserve Communications on Jan 07, 2025 for an estimated value of 1.95K.
Daniel Kwin Grauer Defence Therapeutics (DTCFF)Director
Defence Therapeutics (DTCFF)
Director
Ranked #93,441 out of 100,285 Corporate Insiders
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
-40.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Kwin Grauer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Kwin Grauer
Daniel Kwin Grauer's Trading History
Defence Therapeutics
May 24, 2024
Director
Informative Buy
10.63K
$7.96K
Uniserve Communications
Jan 07, 2025
Director
Informative Buy
1.95K
C$24.53K
List of latest transactions for each holding click on a transaction to see Daniel Kwin Grauer's performance on stock
You May Also Like
Daniel Kwin Grauer insider profile FAQ
What is the percentage of profitable transactions made by Daniel Kwin Grauer?
The percentage of profitable transactions made by Daniel Kwin Grauer is 29%.
What is the average return per transaction made by Daniel Kwin Grauer?
The average return per transaction made by Daniel Kwin Grauer is -40.60%.
What stocks does Daniel Kwin Grauer hold?
Daniel Kwin Grauer holds: DTCFF, TSE:USS stocks.
What was Daniel Kwin Grauer’s latest transaction?
Daniel Kwin Grauer latest transaction was an Informative Buy of C$1.95K.
What was Daniel Kwin Grauer's most profitable transaction?
Daniel Kwin Grauer’s most profitable transaction was an Informative Buy of TSE:USS stock on January 7, 2025. The return on the trade was 4.50%.
What is Daniel Kwin Grauer's role in Defence Therapeutics?
Daniel Kwin Grauer's role in Defence Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.